Effect of Erandamooladi and Shampakadi Basti in the management of ankylosing spondylitis-two case reports
DOI:
https://doi.org/10.70066/jahm.v11i5.898Abstract
Ankylosing spondylitis is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional impairments and a decrease in quality of life. The major causative factors of AS are genetic, with the gene encoding HLA-B27 being the most important genetic factor. Several other susceptibility genes have also been identified. AS is a predominantly genetic disease; HLA-B27 is the most important gene.AS is a gradually progressive condition over several years until structural damage manifests clinically as sacroiliitis, loss of spinal mobility, extra-articular symptoms, peripheral arthritis and reduced quality of life. Various panchakarma procedures and internal Ayurvedic medicines have been proved beneficial in the management of AS. The present two reports deals with a case of Ankylosing spondylitis came to our hospital for Ayurvedic treatment. Both patients were diagnosed as having Aamvata according to Ayurveda and treated with different bastis such as Patient A with Erandmooladi Basti and Patient ‘B’ with Shampakadi Basti after Virechana procedure. Both patients had shown remarkable improvement in their symptoms and also increases their quality of life. Improvement was found in signs and symptoms like fatigue, neck or back or hip pain, tenderness and intensity as well as duration of morning stiffness. Ayurvedic treatment seems to be promising in the management of AS without causing any adverse effects.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Sakshi Gupta

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.